Overview

Study of Aolanti Weikang Tablets in Healthy Volunteers

Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple doses escalation of Aolanti Weikang tablets to determine the MTD in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.